Can you get inactive vaccines right after starting Cosentyx?
Yes, inactive (inactivated) vaccines are safe and recommended after starting Cosentyx (secukinumab), a biologic that suppresses IL-17 for psoriasis, psoriatic arthritis, and ankylosing spondylitis. Unlike live vaccines, which are contraindicated due to infection risk, inactivated ones like flu, polio, hepatitis A/B, HPV, Tdap, and pneumococcal do not replicate and pose no such threat.[1][2]
Timing guidelines for vaccination
Administer inactivated vaccines before starting Cosentyx if possible, ideally 2-4 weeks prior, to maximize immune response—Cosentyx can blunt antibody production even for these vaccines.[1] Post-start, vaccinate anytime; no washout period is needed. Studies show reduced efficacy (e.g., 20-50% lower antibody titers for flu vaccine), so boosters may help high-risk patients.[3][4]
Live vaccines: What to avoid instead
Skip live vaccines (e.g., MMR, varicella, oral polio, yellow fever) during Cosentyx treatment and for 4-6 weeks after stopping, as immunosuppression raises dissemination risk. Restart Cosentyx 2-4 weeks post-vaccination.[1][2]
Real-world evidence from studies
In trials like FUTURE and MEASURE, patients on secukinumab mounted adequate responses to inactivated vaccines like tetanus toxoid and pneumococcal, though slightly weaker than controls. No serious vaccine-related adverse events occurred.[3][5] Clinicians often prioritize these for at-risk groups, like the elderly or those with comorbidities.
Patient concerns: Reduced response and boosters
Some patients worry about "vaccine failure"—Cosentyx lowers seroprotection rates (e.g., 70-90% vs. 95%+ off therapy). Check titers if immunocompromised; annual flu shots and pneumococcal series remain standard.[4][6] Consult your doctor for personalized schedules, especially pre-surgery or travel.
Related biologics: How Cosentyx compares
| Drug | Inactivated Vaccines | Live Vaccines |
|------|----------------------|--------------|
| Cosentyx (IL-17) | Safe, anytime | Avoid |
| Humira (TNF) | Safe, anytime | Avoid |
| Stelara (IL-12/23) | Safe, anytime | Avoid |
| Skyrizi (IL-23) | Safe, anytime | Avoid |
All share similar profiles; no class-wide bans on inactivated shots.[1][2]
Sources:
[1] Cosentyx Prescribing Information - Novartis (https://www.cosentyx.com)
[2] CDC Guidelines on Immunization for Immunocompromised - (https://www.cdc.gov/vaccines)
[3] FUTURE 1 Trial (Ann Rheum Dis 2018) - (https://ard.bmj.com/content/77/12/1690)
[4] EULAR Recommendations (2023) - (https://ard.bmj.com/content/82/1/15)
[5] MEASURE Study (J Rheumatol 2019) - (https://www.jrheum.org/content/46/10/1315)
[6] ACR Guidelines for Vaccinations (2021) - (https://www.rheumatology.org)